Julio Héctor Jova

Nimotuzumab Increases the Recovery Rate of Severe and Critical COVID-19 Patients: Evaluation in the Real-World Scenario

L. Sanchez, P. Lorenzo-Luaces, T. Crombet, 2022, Frontiers in Public Health.